Formulation and Characterization of Proniosomal Gels loaded with Levofloxacin for dermal drug Delivery.

Abstract

Formulation of proniosomal gels and evaluation of their potential in dermal drug delivery of levofloxacin, an antibacterial drug used to treat complicated bacterial infections. Levofloxacin-loaded proniosomal gels were prepared using coacervation phase separation using nonionic surfactants (spans and tweens). Different parameters of the proniosomal gels were evaluated, including particle size (PS), zeta potential (ZP), drug entrapment efficiency percentage (EE%), in vitro drug release, and ex vivo permeation studies. Based on the experimental results, the EE% for the prepared formulas ranged from 32.22±0.86 to 54.83±1.17%. Comparatively to others, levofloxacin could be best encapsulated using span 20. The particle size of the proniosomes ranged from 447±204 nm to 1089±17 nm. Proniosomal gel prepared with span 20 had the smallest vesicle size. The zeta potential range of prepared proniosomes was from 20.95±0 mV to 60.92±0.09 mV. The prepared formulations were found to have a polydispersity index ranging from 0.198±3.23 to 0.967±0.36. Almost all of the formulas displayed a linear release profile ranging from 33.028 to 97.56 percent over 4 hours. A higher level of drug deposition was observed with span 80 compared to tween 80 after 6 h: 18.296% versus 9.44%. The stability study showed that there was no significant change in EE%, PS, or ZP of levofloxacin proniosomal gels after 3 months of storage. In conclusion, the dermal application of the investigated proniosomal gel formulations demonstrated promising results as nanocarriers for levofloxacin.

Unroasted Green Coffee Extract-Loaded Solid Lipid Nanoparticles for Enhancing Intestinal Permeation

“…Our findings agreed with Mohtar et al and Gao et al . Furthermore, the amount of Co-SAA showed an insignificant direct relationship with drug release, which could be explained as propylene glycol acts as a penetration enhancer, so increasing its amount may enhance the release of drugs from SLNs. , The kinetic release pattern was best fitted by the Higuchi model, which was consistent with Yasir and Sara, who reported that the Higuchi kinetic model best described the release of haloperidol from SLNs.…”

Implementing Nanovesicles for Boosting the Skin Permeation of Non-steroidal Anti-inflammatory Drugs

“…Furthermore, proniosomes can integrate drug molecules with different solubilities [56]. Also, they enhance the permeation of drugs through the skin due to the presence of surfactants, as they act as penetration enhancers that interact with the stratum corneum lipophilic barrier [57]. However, proniosomes have some limitations as the large particle-size drugs are not easily absorbed through the skin.…”